Pearls & Oy-sters: Diagnosis of Pediatric Tumefactive Multiple Sclerosis With MRI Biomarkers.

NeurologyOct 1, 2026 (epub)

Kelsey Mackenzie Barter, Aye Thant, Monye Pitt et al.

✦ AI-curated · Sources linked

Case in brief

A 16-year-old boy presented with subacute headaches, cognitive difficulties, dizziness, blurry vision, right arm weakness, numbness, and gait issues. MRI revealed multilobulated, contrast-enhancing lesions in the left frontal lobe and periventricular regions. After initial improvement with steroids, he experienced a recurrence. A follow-up MRI showed lesions with central vein sign, leading to a diagnosis of multiple sclerosis based on the 2024 McDonald criteria.

What made this case unusual

The presence of central vein sign (CVS) in the lesions was pivotal for the diagnosis, distinguishing tumefactive multiple sclerosis from a tumor.

Diagnostic / clinical pearl

Recognition of the central vein sign on MRI is crucial for differentiating tumefactive multiple sclerosis from neoplastic processes, facilitating timely and appropriate treatment.

Why it matters

Accurate diagnosis of tumefactive multiple sclerosis can prevent unnecessary interventions and ensure prompt initiation of effective therapy.

Source

Published in Neurology. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Neurology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.